The course of COVID-19 infection and prolonged sneezing and nasal congestion in a patient using ixekizumab.
作者信息
Güder Semih, Güder Hüsna
机构信息
Department of Dermatology, Medical Faculty, Bezmialem Vakif University, Istanbul, Turkey.
Department of Dermatology, Medical Faculty, Maltepe University, Istanbul, Turkey.
出版信息
Dermatol Ther. 2021 Mar;34(2):e14894. doi: 10.1111/dth.14894. Epub 2021 Feb 23.
Abstract
摘要
相似文献
1
The course of COVID-19 infection and prolonged sneezing and nasal congestion in a patient using ixekizumab.一名使用司库奇尤单抗的患者的新型冠状病毒肺炎感染病程以及持续性打喷嚏和鼻塞情况
Dermatol Ther. 2021 Mar;34(2):e14894. doi: 10.1111/dth.14894. Epub 2021 Feb 23.
2
Sorry, I am sneezing and coughing but I do not have COVID-19.抱歉，我在打喷嚏和咳嗽，但我没有感染新冠病毒。
Brain Behav Immun. 2022 Mar;101:57-58. doi: 10.1016/j.bbi.2021.12.018. Epub 2021 Dec 27.
3
Generation and characterization of humanized synergistic neutralizing antibodies against SARS-CoV-2.生成并鉴定针对 SARS-CoV-2 的人源化协同中和抗体。
J Med Virol. 2022 Aug;94(8):3791-3800. doi: 10.1002/jmv.27801. Epub 2022 May 7.
4
Airborne transmission of SARS-CoV-2 is the dominant route of transmission: droplets and aerosols.新型冠状病毒（SARS-CoV-2）的空气传播是主要传播途径：飞沫和气溶胶传播。
Infez Med. 2021 Mar 1;29(1):10-19.
5
Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）通过呼吸、说话、唱歌、咳嗽和打喷嚏进行空气传播的定量微生物风险评估。
Environ Health Perspect. 2021 Apr;129(4):47002. doi: 10.1289/EHP7886. Epub 2021 Apr 1.
6
Natural nasal-esophageal fiberscopy in the COVID-19 pandemic-preventing sneezing without anesthesia: a case report.在 COVID-19 大流行期间预防打喷嚏而无需麻醉的自然鼻-食管纤维镜检查：一例报告。
Eur J Med Res. 2021 Jun 9;26(1):52. doi: 10.1186/s40001-021-00523-9.
7
Breathing, speaking, coughing or sneezing: What drives transmission of SARS-CoV-2?呼吸、说话、咳嗽或打喷嚏：什么驱动了 SARS-CoV-2 的传播？
J Intern Med. 2021 Nov;290(5):1010-1027. doi: 10.1111/joim.13326. Epub 2021 Jun 8.
8
Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab.一名接受奥瑞珠单抗治疗的患者在接种辉瑞新冠疫苗后抗新冠病毒刺突蛋白抗体反应呈阴性
J Neurol. 2021 Oct;268(10):3592-3594. doi: 10.1007/s00415-021-10463-3. Epub 2021 Feb 27.
9
Development of SARS-CoV-2 IgM and IgG antibodies in a relapsing multiple sclerosis patient on ofatumumab.奥法妥木单抗治疗复发性多发性硬化症患者中 SARS-CoV-2 免疫球蛋白 M 和 G 抗体的产生。
Mult Scler Relat Disord. 2021 Apr;49:102777. doi: 10.1016/j.msard.2021.102777. Epub 2021 Jan 19.
10
Off-label use of tocilizumab in patients with SARS-CoV-2 infection.托珠单抗在新型冠状病毒肺炎患者中的超说明书用药
J Med Virol. 2020 Oct;92(10):1787-1788. doi: 10.1002/jmv.25897. Epub 2020 Jun 29.
本文引用的文献
1
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.意大利 COVID-19 大流行期间接受生物制剂治疗的慢性斑块型银屑病患者的特征：来自 PSO-BIO-COVID 观察性研究的风险分析。
Expert Opin Biol Ther. 2021 Feb;21(2):271-277. doi: 10.1080/14712598.2021.1853698. Epub 2021 Jan 13.
2
"Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.分枝杆菌属暴露或卡介苗接种与 COVID-19 结局的“训练免疫”。
PLoS Pathog. 2020 Oct 29;16(10):e1008969. doi: 10.1371/journal.ppat.1008969. eCollection 2020 Oct.
3
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.以病例为基础的综述：使用司库奇尤单抗治疗的强直性脊柱炎患者的 2019 年冠状病毒病（COVID-19）。
Rheumatol Int. 2020 Oct;40(10):1707-1716. doi: 10.1007/s00296-020-04635-z. Epub 2020 Jun 26.
4
Clinical characteristics of COVID-19 patients combined with allergy.新型冠状病毒肺炎合并过敏患者的临床特征
Allergy. 2020 Sep;75(9):2405-2408. doi: 10.1111/all.14434. Epub 2020 Jun 24.
5
The role of interleukin-17 in asthma: a protective response?白细胞介素-17在哮喘中的作用：一种保护性反应？
ERJ Open Res. 2020 May 26;6(2). doi: 10.1183/23120541.00364-2019. eCollection 2020 Apr.
Zotero 插件